| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $267.6M | -22.4% |
| R&D Expense | $97.4M | +64.0% |
| SG&A Expense | $43.9M | +8.5% |
| Operating Income | $126.3M | -48.4% |
| Pre-tax Income | $148.7M | -42.0% |
| Income Tax | $52.1M | +24.2% |
| Net Income | $96.7M | -54.9% |
| EPS (Basic) | $2.72 | -55.4% |
| EPS (Diluted) | $2.56 | -54.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $284.8M | -66.4% |
| Short-term Investments | $328.4M | — |
| Current Assets | $628.3M | -28.2% |
| Total Assets | $755.0M | -14.7% |
| Current Liabilities | $42.0M | -86.2% |
| Total Liabilities | $91.7M | -72.4% |
| Stockholders' Equity | $663.3M | +20.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$111.2M | -121.7% |
| Capital Expenditures | $938K | -20.6% |
| Investing Cash Flow | -$446.1M | — |
| Financing Cash Flow | $2.0M | -45.8% |
| Free Cash Flow | -$112.1M | -121.9% |